• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测肝移植后早期移植物功能障碍发生率的列线图的开发与验证

Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.

作者信息

Yang L, Xin E Y, Liao B, Lai L J, Han M, Wang X P, Ju W Q, Wang D P, Guo Z Y, He X S

机构信息

Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China; Guangdong Provincial International Cooperation Base of Science and Technology, Guangzhou, China.

Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China; Guangdong Provincial International Cooperation Base of Science and Technology, Guangzhou, China; Pathology Department, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Transplant Proc. 2017 Jul-Aug;49(6):1357-1363. doi: 10.1016/j.transproceed.2017.03.083.

DOI:10.1016/j.transproceed.2017.03.083
PMID:28736007
Abstract

OBJECTIVE

Early allograft dysfunction (EAD) is frequent complication post-liver transplantation and is closely related to recipient's mortality and morbidity. We sought to develop a nomogram for predicting incidence of EAD.

METHODS

Based on multivariate analysis of donor, recipient, and operation data of 199 liver transplants from deceased donors between 2013 and 2015, we identified 5 significant risk factors for EAD to build a nomogram. The model was subjected to prospective validation with a cohort of 42 patients who was recruited between January and June 2016. The predictive accuracy and discriminative ability were measured by area under the receiver operating characteristic curve (AUC). The agreement between nomogram prediction and actual observation was showed by the calibration curve.

RESULTS

Incidence rate of EAD in the training set and validation cohort were 55.91% (104/199) and 54.76% (23/42), respectively. In the training set, according to the results of univariable and multivariable analysis, 5 independent risk factors including donor gender, donor serum gamma-glutamyl transpeptidase level, donor serum urea level, donor comorbidities (respiratory, cardiac, and renal dysfunction), and recipient Model for End-stage Liver Disease score were identified and assembled into the nomogram. The AUC of internal validation using bootstrap resampling and prospective validation using the external cohort of 42 patients was 0.74 and 0.60, respectively. The calibration curves for probability of EAD showed acceptable agreement between nomogram prediction and actual observation. According to the score table, the probability of EAD was under 30% when the total point tally was under 72. But when the total was up to 139, the risk of EAD increased to 60%.

CONCLUSION

We've established and validated a nomogram that can provide individual prediction of EAD for liver transplant recipients. The practical prognostic model may help clinicians to qualify the liver graft accurately, making a more reasonable allocation of organs.

摘要

目的

早期移植肝功能障碍(EAD)是肝移植术后常见的并发症,与受者的死亡率和发病率密切相关。我们试图建立一个预测EAD发生率的列线图。

方法

基于对2013年至2015年间199例脑死亡供者肝移植的供者、受者及手术数据进行多变量分析,我们确定了5个EAD的显著危险因素以构建列线图。该模型在2016年1月至6月招募的42例患者队列中进行前瞻性验证。预测准确性和判别能力通过受试者操作特征曲线下面积(AUC)来衡量。校准曲线显示了列线图预测与实际观察之间的一致性。

结果

训练集和验证队列中EAD的发生率分别为55.91%(104/199)和54.76%(23/42)。在训练集中,根据单变量和多变量分析结果,确定了5个独立危险因素,包括供者性别、供者血清γ-谷氨酰转肽酶水平、供者血清尿素水平、供者合并症(呼吸、心脏和肾功能不全)以及受者终末期肝病模型评分,并将其纳入列线图。使用自举重采样进行内部验证以及使用42例患者的外部队列进行前瞻性验证的AUC分别为0.74和0.60。EAD概率的校准曲线显示列线图预测与实际观察之间具有可接受的一致性。根据评分表,当总分低于72分时,EAD的概率低于30%。但当总分高达139分时,EAD的风险增加到60%。

结论

我们建立并验证了一个可为肝移植受者提供EAD个体预测的列线图。这个实用的预后模型可能有助于临床医生准确评估肝移植供肝,更合理地分配器官。

相似文献

1
Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.预测肝移植后早期移植物功能障碍发生率的列线图的开发与验证
Transplant Proc. 2017 Jul-Aug;49(6):1357-1363. doi: 10.1016/j.transproceed.2017.03.083.
2
A nomogram for prediction of early allograft dysfunction in living donor liver transplantation.用于预测活体肝移植早期移植肝功能障碍的列线图。
Medicine (Baltimore). 2020 Oct 16;99(42):e22749. doi: 10.1097/MD.0000000000022749.
3
Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.肝移植后早期移植物功能障碍两种标准对移植物丢失和死亡率的预测能力分析。
Transplant Proc. 2018 Mar;50(2):605-609. doi: 10.1016/j.transproceed.2017.11.057.
4
Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.基于供体信息预测肝移植早期移植物功能障碍及预后
Liver Int. 2015 Jan;35(1):156-63. doi: 10.1111/liv.12443. Epub 2014 Jan 24.
5
Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.质量较低的器官应该给病情最轻的患者吗?终末期肝病评分和供体风险指数作为早期移植肝功能障碍预测指标的模型。
Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115.
6
Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.利用移植后风险评分模型评估肝移植物早期功能。
JAMA Surg. 2018 May 1;153(5):436-444. doi: 10.1001/jamasurg.2017.5040.
7
Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.慢性乙型肝炎急性肝衰竭预后列线图的开发与验证
J Gastroenterol Hepatol. 2017 Feb;32(2):497-505. doi: 10.1111/jgh.13502.
8
Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.肝移植受者早期移植物功能障碍修订定义相关的预测模型及危险因素
Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13097. Epub 2017 Sep 21.
9
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant.用于评估需要早期肝脏再次移植患者早期移植肝失功的综合模型的开发与验证
JAMA Surg. 2020 Dec 1;155(12):e204095. doi: 10.1001/jamasurg.2020.4095. Epub 2020 Dec 16.
10
Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.供体肝细胞凋亡与肝移植后早期移植物功能障碍和短期移植物存活率降低有关。
Clin Transplant. 2018 Dec;32(12):e13438. doi: 10.1111/ctr.13438. Epub 2018 Nov 22.

引用本文的文献

1
Uric Acid as a Predictor for Early Allograft Dysfunction after Living Donor Liver Transplantation: A Prospective Observational Study.尿酸作为活体供肝移植后早期移植肝功能障碍的预测指标:一项前瞻性观察研究。
J Clin Med. 2021 Jun 21;10(12):2729. doi: 10.3390/jcm10122729.
2
Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study.心脏死亡后供肝肝移植术后早期移植物功能障碍的严重程度:一项多中心研究
Hepatobiliary Surg Nutr. 2021 Jan;10(1):9-19. doi: 10.21037/hbsn.2019.09.02.
3
A nomogram for prediction of early allograft dysfunction in living donor liver transplantation.
用于预测活体肝移植早期移植肝功能障碍的列线图。
Medicine (Baltimore). 2020 Oct 16;99(42):e22749. doi: 10.1097/MD.0000000000022749.
4
First Preliminary Experience with Preservation of Liver Grafts from Extended-Criteria Donors by Normothermic Machine Perfusion in Asia.亚洲首例使用常温机器灌注保存延长标准供肝的初步经验
Ann Transplant. 2020 Apr 21;25:e921529. doi: 10.12659/AOT.921529.
5
A two-circular RNA signature of donor circFOXN2 and circNECTIN3 predicts early allograft dysfunction after liver transplantation.供体circFOXN2和circNECTIN3的双环状RNA特征可预测肝移植后的早期移植物功能障碍。
Ann Transl Med. 2020 Feb;8(4):94. doi: 10.21037/atm.2019.12.132.
6
The postoperative hepatic artery resistance index after living donor liver transplantation can predict early allograft dysfunction.活体肝移植术后肝动脉阻力指数可预测早期移植肝功能障碍。
Medicine (Baltimore). 2020 Jan;99(4):e18677. doi: 10.1097/MD.0000000000018677.
7
Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Role of Factors Affecting the Hepatic Microcirculation and Early Allograft Dysfunction.肝移植中持续充氧(OPAL)研究数据分析:确定影响肝微循环及早期移植物功能障碍的因素的作用
Ann Transplant. 2019 Aug 16;24:481-488. doi: 10.12659/AOT.915214.